<p>Comparison of the Clinical Outcomes Between Nebulized and Systemic Corticosteroids in the Treatment of Acute Exacerbation of COPD in China (CONTAIN Study): A Post Hoc Analysis</p>-Reference-Cited by-同舟云学术

Comparison of the Clinical Outcomes Between Nebulized and Systemic Corticosteroids in the Treatment of Acute Exacerbation of COPD in China (CONTAIN Study): A Post Hoc Analysis

Published:2020-09 Issue: Volume:Volume 15 Page:2343-2353
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Chen Yahong,Liu Yang,Zhang Jing,Yao Wanzhen,Yang Jingping,Li Fan,Lu Liwen,Zheng Jinping^ORCID,Han Xiaowen,Xu Jin-fu^ORCID

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference30 articles.

1. A Subnational Analysis of Mortality and Prevalence of COPD in China From 1990 to 2013

2. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study

3. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

4. Projections of Global Mortality and Burden of Disease from 2002 to 2030

5. Acute Exacerbations of COPD in the United States: Inpatient Burden and Predictors of Costs and Mortality

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert panel consensus recommendations on the utilization of nebulized budesonide for managing asthma and COPD in both stable and exacerbation stages in Thailand;Journal of Asthma;2024-04-03

2. Suboptimal peak inspiratory flow rate: a noticeable risk factor for inhaler concordance in patients with chronic airway diseases;BMJ Open Respiratory Research;2024-04

3. Nebulized corticosteroids versus systemic corticosteroids for patients with acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis comparing the benefits and harms reported by observational studies and randomized controlled trials;Frontiers in Pharmacology;2022-10-05